Dennis Hom is Chief Financial Officer of Sagimet Biosciences Inc.
Person profile
Roles
Sagimet Biosciences
Chief Financial Officer
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 18 Jul 23 | SGMT Sagimet Biosciences | Stock Option Series A Common Stock | Grant | Acquire A | No | No | 6.36 | 136,846 | 870.34 k | 136,846 |
| 18 Jul 23 | SGMT Sagimet Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.36 | 136,846 | 870.34 k | 0 |
| 18 Jul 23 | SGMT Sagimet Biosciences | Stock Option Series A Common Stock | Grant | Acquire A | No | No | 6.36 | 9,286 | 59.06 k | 9,286 |
| 18 Jul 23 | SGMT Sagimet Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.36 | 9,286 | 59.06 k | 0 |
| 18 Jul 23 | SGMT Sagimet Biosciences | Stock Option Series A Common Stock | Grant | Acquire A | No | No | 6.36 | 111,438 | 708.75 k | 111,438 |
| 18 Jul 23 | SGMT Sagimet Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.36 | 111,438 | 708.75 k | 0 |